Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASTROCYTOMA, LOW-GRADE, SOMATIC
|
1 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.700 | 0 | ||||||||
Nongerminomatous Germ Cell Tumor
|
1 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.700 | 0 | ||||||||
melanoma
|
515 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 0.979 | 477 | 2002 | 2020 | |||||
Malignant Neoplasms
|
1641 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.990 | 98 | 2002 | 2020 | |||||
Primary malignant neoplasm
|
1374 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.986 | 69 | 2002 | 2020 | |||||
Colorectal Neoplasms
|
609 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.790 | 0.970 | 33 | 2002 | 2019 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 1.000 | 30 | 2002 | 2019 | |||||
Carcinoma of lung
|
1204 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.750 | 1.000 | 16 | 2002 | 2018 | |||||
Gastrointestinal Stromal Tumors
|
154 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 1.000 | 15 | 2002 | 2019 | |||||
ovarian neoplasm
|
757 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.750 | 1.000 | 12 | 2002 | 2015 | |||||
Neoplasms
|
1644 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 0.947 | 475 | 2003 | 2020 | |||||
Papillary thyroid carcinoma
|
204 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 0.959 | 387 | 2003 | 2019 | |||||
Neoplasm Metastasis
|
327 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.876 | 89 | 2003 | 2019 | |||||
Thyroid Neoplasm
|
135 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.988 | 83 | 2003 | 2020 | |||||
Secondary Neoplasm
|
85 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.909 | 44 | 2003 | 2019 | |||||
Carcinogenesis
|
355 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 0.907 | 43 | 2003 | 2019 | |||||
Cutaneous Melanoma
|
248 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.800 | 1.000 | 26 | 2003 | 2020 | |||||
Carcinoma
|
103 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.100 | 1.000 | 23 | 2003 | 2019 | |||||
Colonic Neoplasms
|
45 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.770 | 0.875 | 8 | 2003 | 2017 | |||||
Multiple Myeloma
|
865 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.770 | 0.875 | 8 | 2003 | 2019 | |||||
Follicular adenoma
|
5 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2003 | 2018 | |||||
Undifferentiated carcinoma
|
8 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.060 | 1.000 | 6 | 2003 | 2015 | |||||
Thyroid Gland Follicular Adenoma
|
14 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.030 | 1.000 | 3 | 2003 | 2018 | |||||
Malignant neoplasm of pancreas
|
277 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.020 | 0.500 | 2 | 2003 | 2015 | |||||
Adult Fibrosarcoma
|
9 | 0.351 | 0.840 | 7 | 140753336 | missense variant | A/C;G;T | snv | 4.0E-06 | 0.010 | 1.000 | 1 | 2003 | 2003 |